Fund search Browse or

SKANDIA AXA FRAMLINGTON BIOTECH PF - Fund overview

No Bestinvest rating

Overview of SKANDIA AXA FRAMLINGTON BIOTECH PF

The fund targets long term capital appreciation by investing principally in the equity securities of companies in the biotechnology, genomic and medical research industries. The fund invests worldwide, but the bulk of the portfolio will consist of US stocks, reflecting the location of much of the biotech industry.

Standard Initial Charge

0.00% 0.00%

Fund summary

Sector	–
Product type	PENSION FUND
Launched	November, 2001
Size	£17m
Yield	0.0%
Charging basis	–
Dividends paid	–
Bid price	115.00p

Fund Charges

Standard Initial charge	0.00%
Initial charge via Bestinvest	0.00%
Additional bid/offer spread	4.96%
Annual management charge	2.40%
Total expense ratio	2.40%
Reduction in yield (10yr)	2.90%

Bestinvest says

This is one of the few authorised funds investing in this highly specialist sector. Historically most of the investments have been located in the USA and share price performance has been closely linked to new drug approvals. The fund's focus is on profitable, large / midcap biotech companies developing specialist medicines.

Portfolio

skandia axa framlington biotech pf asset allocation illustration

Allocation		Proportion

	Equity	98%
	High yield bonds	0%
	Quality bonds	0%
	Property	0%
	Commodities	0%
	Hedge	0%
	Fund cash	2%

skandia axa framlington biotech pf equity geographic illustration

Allocation		Proportion

	UK	3%
	Europe	3%
	Nth America	94%
	Japan	0%
	Pacific	0%
	Other Equity	0%

skandia axa framlington biotech pf equity capitalisation illustration

Allocation		Proportion

	Large Caps	36%
	Mid Caps	30%
	Small Caps	34%

View all performance data for SKANDIA AXA FRAMLINGTON BIOTECH PF

Investment process

No information available.

The value of your investments and the income from them can go down as well as up, and you can get back less than you originally invested. Past performance or any yields quoted should not be considered reliable indicators of future returns. Before investing in funds please check the specific risk factors on the key features document or refer to our risk warning notice as some funds can be high risk or complex; they may also have risks relating to the geographical area, industry sector and/or underlying assets in which they invest. Prevailing tax rates and relief are dependent on your individual circumstances and are subject to change.

Bestinvest (Brokers) Ltd & Bestinvest (Consultants) Ltd are authorised and regulated by the Financial Services Authority. This site is for UK Investors only

Research